|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, February 23, 2017 ) According to Publisher, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs has experienced robust market growth. Some of the factors which are triggering the market growth include growing incidences of diseases, rising demand for biosimilars drugs owing to their cost effectiveness and increasing demand to limit healthcare expenditures. However, stringent government regulations will affect biosimilars investments.
For more information at http://www.reportsweb.com/biosimilar-global-market-outlook-2016-2022 .
Some of the key players in this market include are Mylan, Inc., Dr. Reddy's Laboratories, Amgen Inc., Sandoz International GmbH , Hospira, Inc., Merck KGAA, Celltrion, Inc., Biocon Ltd. , Teva Pharmaceutical Industries Ltd. and Roche Diagnostics.
Products Covered:
- Peptides
- Erythropoietin
- Interferon
- Human Growth Hormone
- Monoclonal Antibodies
- Granulocyte Colony Stimulating Factor (G-CSF)
- Insulin
- Other Products
Technology Covered:
- Bioassay
- Mass Spectrometry
- Nuclear magnetic resonance (NMR) technology
- Recombinant DNA Technology (rDNA technology)
- Western Blotting
- Electrophoresis
- Chromatography
- Monoclonal Antibodies (MAb) Technology
Application Covered:
- Growth Hormone Deficiency
- Chronic and Autoimmune Diseases
- Blood Disorders
- Oncology Diseases
- Other Applications
Service Covered:
- Clinical Trials
- Contract Research and Manufacturing Services
Request Sample Copy: http://www.reportsweb.com/inquiry&RW0001564870/sample .
Regions Covered:
- North America
o US
o Canada
o Mexico
- Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
- Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt
1 Executive Summary
2 Preface
3 Market Trend Analysis
4 Porters Five Force Analysis
5 Global Biosimilar Market, By Product
6 Global Biosimilar Market, By Technology
7 Global Biosimilar Market, By Application
8 Global Biosimilar Market, By Service
9 Global Biosimilar Market, By Geography
10 Key Developments
11 Company Profiling
11.1 Mylan, Inc.
11.2 Dr. Reddy's Laboratories
11.3 Amgen Inc.
11.4 Sandoz International GmbH
11.5 Hospira, Inc.
11.6 Merck KGAA
11.7 Celltrion, Inc.
11.8 Biocon Ltd.
11.9 Teva Pharmaceutical Industries Ltd.
11.10 Roche Diagnostics
11.11 Biogen idec Inc.
11.12 LG Life Sciences
11.13 Synthon Pharmaceuticals, Inc.
11.14 Novartis AG
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001564870/buying .
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
